Cite

HARVARD Citation

    Bae, J. et al. (2021). Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study. Diabetes, obesity & metabolism. 23 (5), pp. 1208-1212. [Online]. 
  
Back to record